Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 19 08 2022
accepted: 09 12 2022
pubmed: 18 12 2022
medline: 1 2 2023
entrez: 17 12 2022
Statut: ppublish

Résumé

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating side effect of chemotherapy. Acupuncture is a promising non-pharmacological intervention for CIPN. However, the physiological effects of acupuncture treatment remain poorly understood. We examined the effects of acupuncture on CIPN using semi-objective quantitative sensory testing (QST). We conducted a randomized controlled trial of real acupuncture (RA) and sham acupuncture (SA) compared to usual care (UC) in cancer survivors with moderate-to-severe CIPN. Treatment response was assessed with QST measures of tactile and vibration detection thresholds in hands and feet, thermal detection, and pain thresholds at weeks 0, 8, and 12. Constrained linear mixed model (cLMM) regression was used for statistical analysis. 63 patients completed QST testing. At week 8, vibrational detection thresholds in feet were significantly lower in RA and SA (p = 0.019 and p = 0.046) than in UC, with no difference between RA and SA (p = 0.637). Both RA and SA also showed significantly higher cool thermal detection than UC (p = 0.008 and p = 0.013, respectively), with no difference between RA and SA (p = 0.790). No differences in tactile detection, vibrational detection in hands, warm thermal detection, and thermal pain thresholds were detected among the three arms at weeks 8 and 12. QST demonstrated different patterns in RA, SA, and UC. After eight weeks of RA, we observed significant improvements in the vibrational detection threshold in feet and cool thermal detection threshold in hands compared to UC. No significant differences were seen when compared to SA. ClinicalTrials.gov (NCT03183037); June 9, 2017.

Identifiants

pubmed: 36527520
doi: 10.1007/s10549-022-06846-3
pii: 10.1007/s10549-022-06846-3
doi:

Substances chimiques

Antineoplastic Agents 0

Banques de données

ClinicalTrials.gov
['NCT03183037']

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

535-545

Subventions

Organisme : Division of Cancer Prevention, National Cancer Institute
ID : P30 CA008748
Organisme : Division of Cancer Prevention, National Cancer Institute
ID : R37CA248563
Organisme : Division of Cancer Prevention, National Cancer Institute
ID : R01CA240417
Organisme : Division of Cancer Prevention, National Cancer Institute
ID : R01CA251470
Organisme : Gateway for Cancer Research
ID : G-22-1200

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Schneider BP, Hershman DL, Loprinzi C (2015) Symptoms: chemotherapy-induced peripheral neuropathy. Adv Exp Med Biol 862:77–87
doi: 10.1007/978-3-319-16366-6_6
Ewertz M, Qvortrup C, Eckhoff L (2015) Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Acta Oncol 54(5):587–591
doi: 10.3109/0284186X.2014.995775
Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, Colvin LA, Fallon M (2014) Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155(12):2461–2470
doi: 10.1016/j.pain.2014.09.020
Hershman DL, Lacchetti C, Loprinzi CL (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline summary. J Oncol Pract 10(6):e421–e424
doi: 10.1200/JOP.2014.001776
Bao T, Basal C, Seluzicki C, Li SQ, Seidman AD, Mao JJ (2016) Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk. Breast Cancer Res Treat 159(2):327–333
doi: 10.1007/s10549-016-3939-0
Rolke R, Magerl W, Campbell KA, Schalber C, Caspari S, Birklein F, Treede RD (2006) Quantitative sensory testing: a comprehensive protocol for clinical trials. Eur J Pain 10(1):77–88
doi: 10.1016/j.ejpain.2005.02.003
Backonja MM, Attal N, Baron R, Bouhassira D, Drangholt M, Dyck PJ, Edwards RR, Freeman R, Gracely R, Haanpaa MH et al (2013) Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus. Pain 154(9):1807–1819
doi: 10.1016/j.pain.2013.05.047
Cata JP, Weng HR, Burton AW, Villareal H, Giralt S, Dougherty PM (2007) Quantitative sensory findings in patients with bortezomib-induced pain. J Pain 8(4):296–306
doi: 10.1016/j.jpain.2006.09.014
Hershman DL, Weimer LH, Wang A, Kranwinkel G, Brafman L, Fuentes D, Awad D, Crew KD (2011) Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy. Breast Cancer Res Treat 125(3):767–774
doi: 10.1007/s10549-010-1278-0
Hanai A, Ishiguro H, Sozu T, Tsuda M, Yano I, Nakagawa T, Imai S, Hamabe Y, Toi M, Arai H et al (2018) Effects of cryotherapy on objective and subjective symptoms of paclitaxel-induced neuropathy: prospective self-controlled trial. J Natl Cancer Inst 110(2):141–148
doi: 10.1093/jnci/djx178
Zhi WI, Chen P, Kwon A, Chen C, Harte SE, Piulson L, Li S, Patil S, Mao JJ, Bao T (2019) Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat 178(3):587–595
doi: 10.1007/s10549-019-05416-4
Zhi WI, Baser RE, Kwon A, Chen C, Li SQ, Piulson L, Seluzicki C, Panageas KS, Harte SE, Mao JJ et al (2021) Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat 186(3):761–768
doi: 10.1007/s10549-020-06079-2
Lin D, De La Pena I, Lin L, Zhou SF, Borlongan CV, Cao C (2014) The neuroprotective role of acupuncture and activation of the BDNF signaling pathway. Int J Mol Sci 15(2):3234–3252
doi: 10.3390/ijms15023234
Zhao ZQ (2008) Neural mechanism underlying acupuncture analgesia. Prog Neurobiol 85(4):355–375
doi: 10.1016/j.pneurobio.2008.05.004
Vickers AJ, Vertosick EA, Lewith G, MacPherson H, Foster NE, Sherman KJ, Irnich D, Witt CM, Linde K, Acupuncture Trialists C (2018) Acupuncture for chronic pain: update of an individual patient data meta-analysis. J Pain 19(5):455–474
doi: 10.1016/j.jpain.2017.11.005
Schroeder S, Meyer-Hamme G, Epplee S (2012) Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupunct Med 30(1):4–7
doi: 10.1136/acupmed-2011-010034
Wong R, Sagar S (2006) Acupuncture treatment for chemotherapy-induced peripheral neuropathy–a case series. Acupunct Med 24(2):87–91
doi: 10.1136/aim.24.2.87
Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schroder S, Bartsch HH (2013) Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med 2013:349653
doi: 10.1155/2013/349653
D’Alessandro EG, Nebuloni Nagy DR, de Brito CMM, Almeida EPM, Battistella LR, Cecatto RB (2019) Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study. BMJ Support Palliat Care. https://doi.org/10.1136/bmjspcare-2018-001542
doi: 10.1136/bmjspcare-2018-001542
Lu W, Giobbie-Hurder A, Freedman RA, Shin IH, Lin NU, Partridge AH, Rosenthal DS, Ligibel JA (2020) Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer survivors: a randomized controlled pilot trial. Oncologist 25(4):310–318
doi: 10.1634/theoncologist.2019-0489
Bao T, Patil S, Chen C, Zhi IW, Li QS, Piulson L, Mao JJ (2020) Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial. JAMA Netw Open 3(3):e200681
doi: 10.1001/jamanetworkopen.2020.0681
Bao T, Baser R, Chen C, Weitzman M, Zhang YL, Seluzicki C, Li QS, Piulson L, Zhi WI (2021) Health-related quality of life in cancer survivors with chemotherapy-induced peripheral neuropathy: a randomized clinical trial. Oncologist. 26(11):e2070–e2078
doi: 10.1002/onco.13933
Drobek W, De Laat A, Schoenaers J (2001) Tactile threshold and pressure pain threshold during treatment of orofacial pain: an explorative study. Clin Oral Invest 5(3):185–193
doi: 10.1007/s007840100125
Kenward MG, White IR, Carpenter JR (2010) Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials? by G. F. Liu, K. Lu, R. Mogg, M. Mallick and D. V. Mehrotra statistics in medicine 2009; 28:2509-2530. Stat Med 29(13):1455–145
doi: 10.1002/sim.3868
Team RC (2021) R: a language and environment for stastical computing. R Foundation for Statistical Computing, Vienna
Bates D, Machler M, Bolker BM, Walker SC (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67(1):1–48
doi: 10.18637/jss.v067.i01
Lenth RV. 2021 emmeans: Estimated Marginal Means, aka Least-Squares Means. In R package version 1.6.3
Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, Clauw DJ (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50(2):613–623
doi: 10.1002/art.20063
Giesbrecht RJ, Battie MC (2005) A comparison of pressure pain detection thresholds in people with chronic low back pain and volunteers without pain. Phys Ther 85(10):1085–1092
doi: 10.1093/ptj/85.10.1085
Puta C, Schulz B, Schoeler S, Magerl W, Gabriel B, Gabriel HH, Miltner WH, Weiss T (2012) Enhanced sensitivity to punctate painful stimuli in female patients with chronic low back pain. BMC Neurol 12:98
doi: 10.1186/1471-2377-12-98
Edwards RR, Sarlani E, Wesselmann U, Fillingim RB (2005) Quantitative assessment of experimental pain perception: multiple domains of clinical relevance. Pain 114(3):315–319
doi: 10.1016/j.pain.2005.01.007
As-Sanie S, Harris RE, Harte SE, Tu FF, Neshewat G, Clauw DJ (2013) Increased pressure pain sensitivity in women with chronic pelvic pain. Obstet Gynecol 122(5):1047–1055
doi: 10.1097/AOG.0b013e3182a7e1f5
Pfau DB, Geber C, Birklein F, Treede RD (2012) Quantitative sensory testing of neuropathic pain patients: potential mechanistic and therapeutic implications. Curr Pain Headache Rep 16(3):199–206
doi: 10.1007/s11916-012-0261-3
Greenspan JD, Slade GD, Bair E, Dubner R, Fillingim RB, Ohrbach R, Knott C, Mulkey F, Rothwell R, Maixner W (2011) Pain sensitivity risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case control study. J Pain 12(11 Suppl):T61-74
doi: 10.1016/j.jpain.2011.08.006
Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH (2003) Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 105(3):403–413
doi: 10.1016/S0304-3959(03)00204-5
Kleinbohl D, Holzl R, Moltner A, Rommel C, Weber C, Osswald PM (1999) Psychophysical measures of sensitization to tonic heat discriminate chronic pain patients. Pain 81(1–2):35–43
doi: 10.1016/S0304-3959(98)00266-8
Reed BD, Sen A, Harlow SD, Haefner HK, Gracely RH (2017) Multimodal vulvar and peripheral sensitivity among women with vulvodynia: a case-control study. J Low Genit Tract Dis 21(1):78–84
doi: 10.1097/LGT.0000000000000267
Naliboff BD, Munakata J, Fullerton S, Gracely RH, Kodner A, Harraf F, Mayer EA (1997) Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 41(4):505–512
doi: 10.1136/gut.41.4.505
Harte SE, Schrepf A, Gallop R, Kruger GH, Lai H, Sutcliffe S, Hartounian S, Halvorson M, Harris RE, Ichesco E et al (2019) Quantitative assessment of non-pelvic pain sensitivity in urological chronic pelvic pain syndrome: a MAPP research network study. Pain. https://doi.org/10.1097/j.pain.0000000000001505
doi: 10.1097/j.pain.0000000000001505
Baron R, Maier C, Attal N, Binder A, Bouhassira D, Cruccu G, Finnerup NB, Haanpaa M, Hansson P, Hullemann P et al (2017) Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles. Pain 158(2):261–272
doi: 10.1097/j.pain.0000000000000753
Lu GW (1983) Characteristics of afferent fiber innervation on acupuncture points zusanli. Am J Physiol 245(4):R606-612
Staff NP, Grisold A, Grisold W, Windebank AJ (2017) Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol 81(6):772–781
doi: 10.1002/ana.24951

Auteurs

W Iris Zhi (WI)

Breast Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Raymond E Baser (RE)

Department of Epidemiology and Biostatistics, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Dristi Talukder (D)

Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ying Zi Mei (YZ)

Barnard College, Columbia University, New York, NY, USA.

Steven E Harte (SE)

Chronic Pain and Fatigue Research Center, Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA.

Ting Bao (T)

Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. baot@mskcc.org.
Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 321 East 61st Street, Room 458, New York, NY, 10065, USA. baot@mskcc.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH